IL10RA and neoplasm: In our recent study, intraperitoneal injections of HPV16 E7 peptides, anti-PD-1, and anti-IL-10R antibody, combined with intratumoral injections of Caerin 1.1 and Caerin 1.9 in subcutaneous tumor-bearing mice, significantly reduced tumor growth rate and prolonged the survival time of tumor-bearing mice [14].